NACFC 2022 | W21: Evidence-Based Medicine: Update on Clinical Trials in Cystic Fibrosis

NACFC 2022 | S31: Stronger Together: Updates from International Clinical TrialsПодробнее

NACFC 2022 | S21: Preclinical Assessment of Novel Genetic TherapiesПодробнее

NACFC 2023 | W21: In Vivo Models, Proof of Concept Trials, and Outcome MeasuresПодробнее

NACFC 2021 | W20: Update on ModulatorsПодробнее

NACFC 2022 | S01: Design of Clinical Trials to Evaluate Nucleotide-Based InterventionsПодробнее

NACFC 2021 | Olivia's Experience in CF Clinical TrialsПодробнее

NACFC 2022 | W16: Updates in Cystic Fibrosis PharmacotherapyПодробнее

NACFC 2022 | DG22: Hot Topics and Trends in Clinical ResearchПодробнее

NACFC 2022 | W33: Best Abstracts in EndocrinologyПодробнее

NACFC 2023 | W22: What’s New in Clinical Trials in CF?Подробнее

NACFC 2022 | S26: Guidelines to ImplementationПодробнее

CF Foundation | NACFC 2022 HighlightsПодробнее

Clinical Trial CoordinationПодробнее

NACFC 2020 | S25: Management of GI Symptoms in Cystic FibrosisПодробнее

NACFC 2022 | DG21: Micronutrient Assessment UpdateПодробнее